Clinical Trial: RHODOS Follow-up Single-visit Study

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial

Brief Summary: This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.

Detailed Summary:
Sponsor: Santhera Pharmaceuticals

Current Primary Outcome: logMAR visual acuity [ Time Frame: measure taken at the single study visit (Week 24) ]

Change in best logMAR visual acuity (Best Acuity) compared to Visit 2/Baseline and Visit 5/Week 24 or last treatment visit of SNT-II-003


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Santhera Pharmaceuticals

Dates:
Date Received: August 19, 2011
Date Started: September 2011
Date Completion:
Last Updated: May 24, 2013
Last Verified: May 2013